CTRI/2022/08/044760已完成4 期
Early Neutral Protamine Hagedorn Insulin in the management of Diabetic Ketoacidosis â?? An Exploratory Study in a Low Resource Setting.
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All adults > 18 years of age with DKA.
- •DKA is defined as a patients having all of the following
- •RBS >250mg/dl
- •Urine ketones ++(dipstick)
- •Bicarbonates <18 Anion gap > 10
排除标准
- •1.Chronic Liver Disease
- •2.Chronic Kidney Disease
- •3.Patient on Assisted mechanical ventilation
- •4.Hypotensive patients on inotropic support
研究者
相似试验
已完成
不适用
Effects of INsulin dEtemiR and neutral protaminE hagedorn (nph) insulin on BRain glucOse metabolism: a study in persons with type 1 diabetes10018424type 1 diabetesNL-OMON33980Vrije Universiteit Medisch Centrum40
终止
4 期
Use of NPH Versus Basal Bolus Insulin for Steroid Induced HyperglycemiaHyperglycemia Steroid-inducedInsulin Resistance, DiabetesNCT03511521Northwestern University3
已完成
不适用
INITIATE (INITiate Insulin by Aggressive Titration and Education): a randomised study to compare initiation of insulin combination therapy in type two diabetic patients individually and in groupsType 2 diabetesNutritional, Metabolic, EndocrineDiabetesISRCTN09079822sanofi-aventis Oy (Finland)120
进行中（未招募）
不适用
Pre-POINT (Primary Oral/intranasal INsulin Trial) study A dose finding safety and immune efficacy study for primary mucosal insulin therapy in islet autoantibody negative children at high genetic risk for type 1 diabetes - Pre-POINTpre-type 1 diabetes (islet autoimmunity in non-diabetic relatives of subjects with type 1 diabetes)EUCTR2005-001621-29-ATFaculty of Medicine Carl Gustav Carus, University of Technology, Dresden40
进行中（未招募）
1 期
Insulina humana preprandial inhalada con el sistema AERx® iDMS frente a insulina aspart s.c. en diabetes tipo 2: ensayo de 52 semanas de duración, abierto, multicéntrico, aleatorizado seguido de un periodo de extensión de 52 semanas y una extensión de 12 semanas con re-aleatorización para investigar la seguridad y la eficacia.Inhaled pre-prandial human insulin with the AERx® iDMS versus s.c. insulin aspart in type 2 diabetes;Diabetes MellitusEUCTR2005-005378-58-ESovo Nordisk A/S